Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study

BACKGROUND: Osteosarcoma is the most prevalent primary malignant bone tumor. The primary treatment for osteosarcoma is a combination of chemotherapy and surgery. However, there has been no recent progress in the role of chemotherapy in improving the long-term survival of osteosarcoma patients. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinkui, Li, Mujie, Guo, Peng, He, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304229/
https://www.ncbi.nlm.nih.gov/pubmed/37370182
http://dx.doi.org/10.1186/s13018-023-03922-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304229/
https://www.ncbi.nlm.nih.gov/pubmed/37370182
http://dx.doi.org/10.1186/s13018-023-03922-2

Ejemplares similares